Retina

The rationale for enabling nurses to inject dexamethasone implants

February 26, 2021

Nurses and other allied healthcare professionals can safely and effectively deliver intravitreal steroid implants in a clean room setting, which has reduced patient waiting times.

Addressing gaps in treatment of AMD

February 14, 2021

Aleksandra Rachitskaya, MD, speaks on the current gaps in AMD treatment as well as ongoing retinal advancements to help address unmeet needs of patients.

The increasing potential of electroretinography in ophthalmic diagnostics

February 09, 2021

Recent improvements in electroretinography are making the technique more accessible for general use. It has a wide range of clinical applications.

Emerging therapies for AMD management

February 07, 2021

Anat Loewenstein, MD, provides an update on the latest developments in emerging therapies for the management of age-related macular degeneration (AMD) and wet AMD.

Examining 3 major risk factors of AMD

February 05, 2021

Joshua Mali, MD, discusses the three major risk factors for developing age-related macular degeneration (AMD).

Learning the basics of age-related macular degeneration

February 03, 2021

Ian C. Han, MD, assistant professor in the Department of Ophthalmology and Visual Sciences, Institute for Vision Research, University of Iowa Hospital and Clinics, dives into the basics of age-related macular degeneration (AMD) and what patients need to know.

Investigators research astronauts’ ocular health following space flights

January 29, 2021

With NASA’s sights set on Mars, continued research into further understanding and mitigating spaceflight-associated neuro-ocular syndrome is of the utmost importance for astronaut health and space exploration.

The state of wet & dry AMD in 2021

January 28, 2021

Rishi P. Singh, MD, highlights various treatment options available for the management of patients with age-related macular degeneration, as well as the status of potential therapies.

Investigators explore pathogenic cytokines as biomarkers for DMO

January 27, 2021

Results of a study analysing cytokine levels in the aqueous humour and serum of patients with nonproliferative diabetic retinopathy with and without diabetic macular oedema support further research investigating transforming growth factor-β-induced Gene Human Clone 30 (BIGH3) as a potential biomarker for DMO.

Treating vitreous opacities with YAG vitreolysis

January 20, 2021

Study found that YAG laser vitreolysis was less invasive than pars plana vitrectomy for patients with vitreous opacities.